Finance
Results: 3961-3972 of 41647

Sinch reports fourth quarter and full-year 2025 results - strengthened financial performance and continued market leadership

Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness






